| 发明名称 |
Growth hormones with prolonged in-vivo efficacy |
| 摘要 |
The present invention relates to polypeptide compound optimized for subcutaneous administration, exemplified by growth hormone conjugates having a linker providing non-covalent binding to albumin. |
| 申请公布号 |
US8841249(B2) |
申请公布日期 |
2014.09.23 |
| 申请号 |
US201013389180 |
申请日期 |
2010.08.06 |
| 申请人 |
Novo Nordisk A/S |
发明人 |
Johansen Nils Langeland;Andersen Henrik Sune;Buchardt Jens;Norskov-Lauritsen Leif |
| 分类号 |
A61K38/27;C07K14/61 |
主分类号 |
A61K38/27 |
| 代理机构 |
|
代理人 |
Hu Jianjie |
| 主权项 |
1. A growth hormone conjugate selected from the group consisting of |
| 地址 |
Bagsvaerd DK |
